ArticleJournal of clinical immunology2013

Are transglutaminase 2 inhibitors able to reduce gliadin-induced toxicity related to celiac disease? A proof-of-concept study.

Tiina Rauhavirta et al.PubMed ↗Publisher ↗

No numbers read from the abstract.